Cargando…
Systemic treatment of patients with metachronous peritoneal carcinomatosis of colorectal origin
Combining chemotherapy and targeted therapies has resulted in an enhanced survival in metastatic colorectal cancer (mCRC) patients. However, the result of this palliative treatment in patients with metachronous peritoneal carcinomatosis (PC) remains unknown. The current population-based study aims t...
Autores principales: | van Oudheusden, T. R., Razenberg, L. G., van Gestel, Y. R., Creemers, G. J., Lemmens, V. E., de Hingh, I. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685443/ https://www.ncbi.nlm.nih.gov/pubmed/26686250 http://dx.doi.org/10.1038/srep18632 |
Ejemplares similares
-
Bevacizumab for metachronous metastatic colorectal cancer: a reflection of community based practice
por: Razenberg, L. G. E. M., et al.
Publicado: (2016) -
Treatment Strategies and Prognosis of Patients With Synchronous or Metachronous Colorectal Peritoneal Metastases: A Population-Based Study
por: Bakkers, C., et al.
Publicado: (2021) -
Molecular fluorescence‐guided surgery of peritoneal carcinomatosis of colorectal origin: A narrative review
por: Hentzen, Judith E.K.R., et al.
Publicado: (2018) -
Asymptomatic peritoneal carcinomatosis originating from benign cystic peritoneal mesothelioma
por: Iacoponi, S, et al.
Publicado: (2015) -
Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum
por: Lemoine, Lieselotte, et al.
Publicado: (2016)